Yanzhen Tan
127 Changle West Road
Xi'an, 710032, China
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Impaired hepatic BMAL1-FGF21 signaling drives adverse metabolic outcomes of ketogenic diet.
Journal: Life sciences
Published: January 22, 2026
The tryptophan metabolite indole 3-propionic acid alleviates lung ischemia-reperfusion injury via prostaglandin reductase 2 in male mice.
Journal: Biochemical pharmacology
Published: June 30, 2025
N-terminal domain of CTRP9 promotes cardiac fibroblast activation in myocardial infarction via Rap1/Mek/Erk pathway.
Journal: Journal of translational medicine
Published: December 07, 2024
Early-life exercise extends healthspan but not lifespan in mice.
Journal: Nature communications
Published: July 18, 2024
Cardiac Urea Cycle Activation by Time-Restricted Feeding Protects Against Pressure Overload-Induced Heart Failure.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 09, 2024
CTRP3 alleviates mitochondrial dysfunction and oxidative stress injury in pathological cardiac hypertrophy by activating UPRmt via the SIRT1/ATF5 axis.
Journal: Cell death discovery
Published: August 16, 2023
Epicardial adipose tissue, metabolic disorders, and cardiovascular diseases: recent advances classified by research methodologies.
Journal: MedComm
Published: March 14, 2023
Forkhead box O6 (FoxO6) promotes cardiac pathological remodeling and dysfunction by activating Kif15-TGF-β1 under aggravated afterload.
Journal: MedComm
Published: March 11, 2023
GLUT4 mediates the protective function of gastrodin against pressure overload-induced cardiac hypertrophy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 10, 2022
Bergenin alleviates myocardial ischemia-reperfusion injury via SIRT1 signaling.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 04, 2022
Last Updated: 09/26/2026